Year |
Citation |
Score |
2020 |
Wynn Mon S, Myint Zu WW, Myint Maw M, Win H, Zin Thant K, Yang G, Malhotra C, Teo I, Finkelstein E, Ozdemir S. Awareness of and preference for disease prognosis and participation in treatment decisions among advanced cancer patients in Myanmar: Results from the APPROACH study. Asia-Pacific Journal of Clinical Oncology. PMID 32921003 DOI: 10.1111/Ajco.13430 |
0.301 |
|
2020 |
Malhotra C, Krishnan A, Yong JR, Teo I, Ozdemir S, Ning XH, Hapuarachchi T, Palat G, Bhatnagar S, Joad AK, Tuong PN, Ssu WM, Finkelstein E. Socio-economic inequalities in suffering at the end of life among advanced cancer patients: results from the APPROACH study in five Asian countries. International Journal For Equity in Health. 19: 158. PMID 32912232 DOI: 10.1186/S12939-020-01274-5 |
0.35 |
|
2020 |
Mon SW, Ozdemir S, Zu WWM, Win H, Maw MM, Win KC, Thant KZ, Teo I, Krishnan A, Goh CR, Finkelstein EA, Malhotra C. End of life experiences of patients with advanced cancer in Myanmar: Results from the APPROACH study. Asia-Pacific Journal of Clinical Oncology. PMID 32573100 DOI: 10.1111/Ajco.13373 |
0.319 |
|
2020 |
Tan CW, Ozdemir S, Baid D, Rehena S, Tan ZZY, Sia ATH, Finkelstein E, Sng BL. Patients' preferences and trade-off during labour epidural analgesia: A discrete choice experiment. Journal of Clinical Anesthesia. 66: 109919. PMID 32570071 DOI: 10.1016/J.Jclinane.2020.109919 |
0.301 |
|
2019 |
Malhotra C, Harding R, Teo I, Ozdemir S, Koh GCH, Neo P, Lee LH, Kanesvaran R, Finkelstein E. Financial difficulties are associated with greater total pain and suffering among patients with advanced cancer: results from the COMPASS study. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 31832824 DOI: 10.1007/S00520-019-05208-Y |
0.312 |
|
2019 |
Jacob J, Palat G, Verghese N, Chandran P, Rapelli V, Kumari S, Malhotra C, Teo I, Finkelstein E, Ozdemir S. Health-related quality of life and its socio-economic and cultural predictors among advanced cancer patients: evidence from the APPROACH cross-sectional survey in Hyderabad-India. Bmc Palliative Care. 18: 94. PMID 31690311 DOI: 10.1186/S12904-019-0465-Y |
0.331 |
|
2019 |
Han E, Shiraz F, Haldane V, Koh JJK, Quek RYC, Ozdemir S, Finkelstein EA, Jafar TH, Choong HL, Gan S, Lim LWW, Legido-Quigley H. Biopsychosocial experiences and coping strategies of elderly ESRD patients: a qualitative study to inform the development of more holistic and person-centred health services in Singapore. Bmc Public Health. 19: 1107. PMID 31412824 DOI: 10.1186/S12889-019-7433-6 |
0.327 |
|
2018 |
Malhotra C, Foo R, Singh R, Ozdemir S, Teo I, Sim D, Jaufeerally F, Aung T, Keong YK, Nadkarni N, Finkelstein EA. Study protocol for a cohort study of patients with advanced heart failure in Singapore. Bmj Open. 8: e022248. PMID 30224389 DOI: 10.1136/Bmjopen-2018-022248 |
0.304 |
|
2018 |
Teo I, Singh R, Malhotra C, Ozdemir S, Dent RA, Kumarakulasinghe NB, Yeo WL, Cheung YB, Malhotra R, Kanesvaran R, Yee ACP, Chan N, Wu HY, Chin SM, Allyn HYM, et al. Cost of Medical Care of Patients with Advanced Serious Illness in Singapore (COMPASS): prospective cohort study protocol. Bmc Cancer. 18: 459. PMID 29688843 DOI: 10.1186/S12885-018-4356-Z |
0.328 |
|
2017 |
Ozdemir S, Wong TT, Allingham RR, Finkelstein EA. Predicted patient demand for a new delivery system for glaucoma medicine. Medicine. 96: e6626. PMID 28403115 DOI: 10.1097/Md.0000000000006626 |
0.309 |
|
2016 |
Dong D, Ozdemir S, Mong Bee Y, Toh SA, Bilger M, Finkelstein E. Measuring High-Risk Patients' Preferences for Pharmacogenetic Testing to Reduce Severe Adverse Drug Reaction: A Discrete Choice Experiment. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 19: 767-775. PMID 27712704 DOI: 10.1016/J.Jval.2016.03.1837 |
0.31 |
|
2016 |
Ozdemir S, Johnson FR, Whittington D. Process, Ideology, and Willingness to Pay for Reducing Childhood Poverty Journal of Benefit-Cost Analysis. 7: 373-399. DOI: 10.1017/Bca.2016.17 |
0.463 |
|
2016 |
Ozdemir S, Johnson FR, Whittington D. Ideology, public goods and welfare valuation: An experiment on allocating government budgets Journal of Choice Modelling. 20: 61-72. DOI: 10.1016/J.Jocm.2016.07.003 |
0.486 |
|
2013 |
Jeuland MA, Fuente DE, Ozdemir S, Allaire MC, Whittington D. The long-term dynamics of mortality benefits from improved water and sanitation in less developed countries. Plos One. 8: e74804. PMID 24116011 DOI: 10.1371/Journal.Pone.0074804 |
0.61 |
|
2010 |
Johnson FR, Hauber B, Özdemir S, Siegel CA, Hass S, Sands BE. Are gastroenterologists less tolerant of treatment risks than patients? Benefit-risk preferences in Crohn's disease management. Journal of Managed Care Pharmacy : Jmcp. 16: 616-28. PMID 20866166 DOI: 10.18553/Jmcp.2010.16.8.616 |
0.319 |
|
2010 |
Johnson FR, Hauber AB, Ozdemir S, Lynd L. Quantifying women's stated benefit-risk trade-off preferences for IBS treatment outcomes. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 13: 418-23. PMID 20230550 DOI: 10.1111/J.1524-4733.2010.00694.X |
0.326 |
|
2009 |
Johnson FR, Van Houtven G, Ozdemir S, Hass S, White J, Francis G, Miller DW, Phillips JT. Multiple sclerosis patients' benefit-risk preferences: serious adverse event risks versus treatment efficacy. Journal of Neurology. 256: 554-62. PMID 19444531 DOI: 10.1007/S00415-009-0084-2 |
0.3 |
|
2009 |
Johnson FR, Ozdemir S, Mansfield C, Hass S, Siegel CA, Sands BE. Are adult patients more tolerant of treatment risks than parents of juvenile patients? Risk Analysis : An Official Publication of the Society For Risk Analysis. 29: 121-36. PMID 18826414 DOI: 10.1111/J.1539-6924.2008.01135.X |
0.334 |
|
2009 |
Boyle KJ, Özdemir S. Convergent Validity of Attribute-Based, Choice Questions in Stated-Preference Studies Environmental and Resource Economics. 42: 247-264. DOI: 10.1007/S10640-008-9233-9 |
0.309 |
|
2007 |
Johnson FR, Ozdemir S, Mansfield C, Hass S, Miller DW, Siegel CA, Sands BE. Crohn's disease patients' risk-benefit preferences: serious adverse event risks versus treatment efficacy. Gastroenterology. 133: 769-79. PMID 17628557 DOI: 10.1053/J.Gastro.2007.04.075 |
0.323 |
|
2007 |
Johnson F, Ozdemir S, Mansfield C, Hauber A, Hass S, Siegel C, Sands B, Miller D. Pr3 Patients', Parents', And Physicians' Risk-Benefit Trade-Off Preferences For Crohn'S Disease Treatments Value in Health. 10. DOI: 10.1016/S1098-3015(10)64868-1 |
0.308 |
|
2006 |
Johnson F, Özdemir S, Mansfield C, Sands B, Siegel C, Hass S, Miller D, White T. Pgi22 Weighing Treatment Benefits Against Treatment Risks: Crohn'S Disease Patients'Willingness To Accept Risk-Benefit Tradeoffs Value in Health. 9. DOI: 10.1016/S1098-3015(10)64459-2 |
0.311 |
|
2006 |
Johnson F, Houtven GV, Mansfield C, Özdemir S, Miller D. Pr2 Quantifying Patients' Risk-Benefit Tradeoff Preferences: A Conceptual And Empirical Comparison Of Methods Value in Health. 9. DOI: 10.1016/S1098-3015(10)64328-8 |
0.319 |
|
Show low-probability matches. |